Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 104.40
-2.40 (-2.25%)
May 25, 2026, 5:29 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 14.14 billion as of May 22, 2026. Its market cap has decreased by -32.95% in one year.
Market Cap
14.14B
Enterprise Value
14.84B
Revenue
3.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
104.40
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 14.14B, an increase of 2,667.57%. That is a compound annual growth rate of 14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 14.46B | -22.04% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Sectra AB | 52.87B |
| Elekta AB | 23.04B |
| Nolato AB | 13.32B |
| Xvivo Perfusion AB | 9.23B |
| MedCap AB | 8.35B |
| CellaVision AB | 2.97B |
| Devyser Diagnostics AB | 1.62B |